Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
Effect Of Tolvaptan On Egfr Left Panel And Tkv Right Panel By Ckd
Effect Of Tolvaptan On Egfr Left Panel And Tkv Right Panel By Ckd
850×258
Egfr Progression Slopes Mlmin173 M2year For Male And Female
Egfr Progression Slopes Mlmin173 M2year For Male And Female
527×329
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
640×640
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
640×640
Predicted And Observed Egfr Over Time A Average Predicted Egfr
Predicted And Observed Egfr Over Time A Average Predicted Egfr
850×1360
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
640×640
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
Tolvaptan Effect On Egfr Slope Mlmin Per 173 M 2 Year In Tempo 34
850×417
Annual Tkv Growth And Change In Egfr A For Tolvaptan Versus Placebo
Annual Tkv Growth And Change In Egfr A For Tolvaptan Versus Placebo
850×779
Calculated Egfr Mlmin173 M 2 During The Clinical Follow Up There
Calculated Egfr Mlmin173 M 2 During The Clinical Follow Up There
695×449
Change In Kidney Function During Tolvaptan Long Term Treatment The
Change In Kidney Function During Tolvaptan Long Term Treatment The
850×1055
Correlation Between Observed And Predicted Egfr Mlmin Per 173 M 2
Correlation Between Observed And Predicted Egfr Mlmin Per 173 M 2
850×1162
Gfr Mlmin Per 173 M 2 Evolution Displayed In A Box Plot Showing
Gfr Mlmin Per 173 M 2 Evolution Displayed In A Box Plot Showing
850×579
Forest Plot Of Egfr Slope Mlmin Per 173 M² Per Year Between
Forest Plot Of Egfr Slope Mlmin Per 173 M² Per Year Between
850×726
Egfr Slope Mlmin173m 2 Year And Risk For Progression By One
Egfr Slope Mlmin173m 2 Year And Risk For Progression By One
850×462
Patients With Egfr ‡60 Mlmin Per 173 M 2 Preoperatively Had A
Patients With Egfr ‡60 Mlmin Per 173 M 2 Preoperatively Had A
850×750
One Year Estimated Gfr Slope Independently Predicts Clinical Benefit In
One Year Estimated Gfr Slope Independently Predicts Clinical Benefit In
3404×1598
The Risk Of Fast Egfr Slope In The Sub Group A Egfr Slope Download
The Risk Of Fast Egfr Slope In The Sub Group A Egfr Slope Download
586×586
Estimated Glomerular Filtration Rate Egfr Slope During The First 3
Estimated Glomerular Filtration Rate Egfr Slope During The First 3
850×808
Annualized Egfr Slope Mlmin173 M 2 Year In Groups Of Children
Annualized Egfr Slope Mlmin173 M 2 Year In Groups Of Children
850×385
Correlation Between Loss Of Egfr And Aopps Correlation Between Egfr
Correlation Between Loss Of Egfr And Aopps Correlation Between Egfr
650×664
Egfr Slopes Mlmin173 M 2 Per Year By Image Based Classification
Egfr Slopes Mlmin173 M 2 Per Year By Image Based Classification
640×640
Validation Of Tolvaptan Treatment Effect Applied In The Adpkd Outcomes
Validation Of Tolvaptan Treatment Effect Applied In The Adpkd Outcomes
850×1593
Adjusted Hr Of Esrd Associated With Slope Of Egfr During A 3 Year
Adjusted Hr Of Esrd Associated With Slope Of Egfr During A 3 Year
525×525
Baseline Demographics By Egfr Slope Category Egfr Slope Mlmin173 M
Baseline Demographics By Egfr Slope Category Egfr Slope Mlmin173 M
640×640
Distribution Of Measured Gfr Mgfr Mlmin Per 173 M 2 And Urinary
Distribution Of Measured Gfr Mgfr Mlmin Per 173 M 2 And Urinary
850×535
Effect Of Tolvaptan On The Rate Of Change In Tkv And The Decline In
Effect Of Tolvaptan On The Rate Of Change In Tkv And The Decline In
605×605
Effect Of Tolvaptan On Renal Handling Of Water And Sodium Gfr And
Effect Of Tolvaptan On Renal Handling Of Water And Sodium Gfr And
567×212
Averaged Estimated Effect Of Time On Egfr Mlmin 172 M 2
Averaged Estimated Effect Of Time On Egfr Mlmin 172 M 2
530×530
Annualized Egfr Slope Mlmin173 M 2 Year In Groups Of Children
Annualized Egfr Slope Mlmin173 M 2 Year In Groups Of Children
640×640
Egfr Slopes Mlmin173 M 2 Per Year By Image Based Classification
Egfr Slopes Mlmin173 M 2 Per Year By Image Based Classification
850×197
Tolvaptan Preserved Renal Functions And Decreased Blood Urea
Tolvaptan Preserved Renal Functions And Decreased Blood Urea
850×629
Baseline Characteristics Of The Primary Cohort A Egfr Mlmin Per
Baseline Characteristics Of The Primary Cohort A Egfr Mlmin Per
850×321
Yearly Change Of Gfr Mlminm 2 Per Year According To Download
Yearly Change Of Gfr Mlminm 2 Per Year According To Download
733×485
